- Global Pharma News & Resources

Parkinson's Disease Therapeutics Market - Global Industry Analysis, Trends, Size and Forecasts 2016-2024 -

The "Parkinson's disease Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to's offering.

The report predicts the global Parkinson's disease therapeutics market to grow with a CAGR of 5.8% over the forecast period of 2018-2024. The report on global Parkinson's disease therapeutics market provides qualitative and quantitative analysis for the period of 2016 to 2024.

Some of the major factors driving the growth of this market are rising growth in aged population joined with growing frequency of Parkinson's disease in the developed countries is boosting the growth of the Parkinson's disease therapeutics market. Furthermore, growing environmental factors and genetic heredity are also facilitating the growth of the market.

Furthermore, upsurge in consciousness regarding Parkinson's disease and high clinical R&D budget by the governments and non-profit organizations are anticipated to boost the growth of this market over upcoming years. The favorable product pipeline represents the potential development opportunities during the forecast period. On the other hand expiration of patent drugs is projected to hamper the market growth.

Geographically, North America is expected to hold the largest market share in Parkinson's disease Therapeutics Market followed by Europe and Asia Pacific. Growth in North America region is mainly due to growing spending on healthcare, developed healthcare infrastructure and promising medical compensation policies.

Factors responsible for the growth in Europe region is owing to growing government enterprises for promoting the healthcare sector and augmented adoption of research and development activities in this region.

Furthermore, Asia Pacific region is driven by growing numbers of healthcare organizations, growth in geriatric population and growing frequency of Parkinson's disease.

Segment Covered

Global Parkinson's disease Therapeutics Market by Drug Class

  • Carbidopa/Levodopa
  • Dopamine Receptor Agonists
  • Mao Inhibitors
  • Comt Inhibitors
  • Anticholinergics
  • Other Drugs

Global Parkinson's disease Therapeutics Market by Distribution Channel

  • Hospital Pharmacies
  • Retailer Pharmacies
  • Online Pharmacies

Global Parkinson's disease Therapeutics Market by End User

  • Hospitals
  • Clinics

Company Profiles

  • GSK
  • Merck
  • Novartis
  • Teva
  • Boehringer Ingelheim
  • Impax
  • Abbvie
  • Valeant Pharmaceuticals
  • Lundbeck
  • Sun Pharma

For more information about this report visit

View source version on

Editor Details

Last Updated: 31-Oct-2018